Balkar ME. Comment on The renin-angiotensin system in models of pulmonary arterial hypertension vs primary hypertension. Hypertens Res. 2026. https://doi.org/10.1038/s41440-026-02675-9.

Article  PubMed  Google Scholar 

Nakayama Y, Eguchi S. The renin-angiotensin system in models of pulmonary arterial hypertension vs primary hypertension. Hypertens Res. 2025;48:2522–6.

Article  PubMed  Google Scholar 

Provencher S, Archer SL, Ramirez FD, Hibbert B, Paulin R, Boucherat O, et al. Standards and methodological rigor in pulmonary arterial hypertension preclinical and translational research. Circ Res. 2018;122:1021–32.

Article  PubMed  Google Scholar 

Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 2009;297:L1013–32.

Article  PubMed  Google Scholar 

Machado RD, Southgate L, Eichstaedt CA, Aldred MA, Austin ED, Best DH, et al. Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects. Hum Mutat. 2015;36:1113–27.

Article  PubMed  PubMed Central  Google Scholar 

D’Alessandro A, El Kasmi KC, Plecita-Hlavata L, Jezek P, Li M, Zhang H, et al. Hallmarks of pulmonary hypertension: mesenchymal and inflammatory cell metabolic reprogramming. Antioxid Redox Signal. 2018;28:230–50.

Article  PubMed  Google Scholar 

Lahm T, Hess E, Baron AE, Maddox TM, Plomondon ME, Choudhary G, et al. Renin-angiotensin-aldosterone system inhibitor use and mortality in pulmonary hypertension: insights from the veterans affairs clinical assessment reporting and tracking database. Chest. 2021;159:1586–97.

Article  PubMed  Google Scholar 

Pinheiro SV, Simoes e Silva AC, Sampaio WO, de Paula RD, Mendes EP, Bontempo ED, et al. Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. Hypertension. 2004;44:490–6.

Article  PubMed  Google Scholar 

Yuan R, Liu M, Cheng Y, Yan F, Zhu X, Zhou S, et al. Biomimetic nanoparticle-mediated target delivery of hypoxia-responsive plasmid of angiotensin-converting enzyme 2 to reverse hypoxic pulmonary hypertension. ACS Nano. 2023;17:8204–22.

Article  PubMed  Google Scholar 

Mamazhakypov A, Lother A. Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research. Front Cardiovasc Med. 2023;10:1118516.

Article  PubMed  PubMed Central  Google Scholar